<DOC>
	<DOC>NCT01860196</DOC>
	<brief_summary>This study aimed to compare the efficacy and safety of Meditoxin® injection for cervical dystonia in adults with cerebral palsy. It is a placebo controlled, Cross-over, Double blind, Randomized, Clinical trial.</brief_summary>
	<brief_title>Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<criteria>Adult cerebral palsy patients over 20 years old Clinically diagnosed for cervical dystonia more than a year ago No improvement with antispasmodics for the last month Actively participated and gave informed consent Allergic to the botulinum toxin Limited range of motion in cervical spine Patients with fever, infection, cancer, uncontrollable seizure Generalized neuromuscular junction disease patients Pregnant or breast feeding women, or anticipating pregnancy until 12 weeks after the study stopped Patients enrolled in other studies History of dose change in 4 weeks: antispasmodics, benzodiazepine, anticholinergics Botulinum toxin injection history in 6 months Previous history of intrathecal baclofen, selective peripheral denervation, deep brain stimulation Otherwise clinically noneligible patients</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>